Latest Articles
Understanding Endometrial Cancer: One Patient’s Story - Medscape
Understanding Endometrial Cancer: One Patient’s Story Medscape
Published: Jan. 20, 2026, 5:06 p.m.
ESMO Preceptorship on Endometrial Cancer 2026: Lugano - Oncodaily
ESMO Preceptorship on Endometrial Cancer 2026: Lugano Oncodaily
Published: Jan. 20, 2026, 3:14 p.m.
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - BIOENGINEER.ORG
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment BIOENGINEER.ORG
Published: Jan. 19, 2026, 3:06 p.m.
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - Bioengineer.org
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment Bioengineer.org
Published: Jan. 19, 2026, 3:06 p.m.
Bridging Disparities in Endometrial Cancer Care - Medscape
Bridging Disparities in Endometrial Cancer Care Medscape
Published: Jan. 16, 2026, 1:50 p.m.
Reflections on Evolving Endometrial Cancer Care - Medscape
Reflections on Evolving Endometrial Cancer Care Medscape
Published: Jan. 16, 2026, 1:40 p.m.
Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer - Cancer Health
Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer Cancer Health
Published: Jan. 15, 2026, 1:34 p.m.
Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers - koreabiomed.com
Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers koreabiomed.com
Published: Jan. 15, 2026, 6:21 a.m.
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? - Oncology Nursing News
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? Oncology Nursing News
Published: Jan. 14, 2026, 7:32 p.m.
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity TipRanks
Published: Jan. 14, 2026, 4:33 p.m.
Link copied to clipboard!